Similar medications and substitutes for PALIVIZUMAB
In short: Synagis (PALIVIZUMAB) belongs to the Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Synagis is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Synagis in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.